Life ScienceCompany
Where is Cyclo Therapeutics headquartered?
Cyclo Therapeutics is headquartered in Gainesville, Florida.
What sector is Cyclo Therapeutics in?
Cyclo Therapeutics is a life science company.
Cyclo Therapeutics is headquartered in Gainesville, Florida.
Cyclo Therapeutics is a life science company.
6714 NW 16th Street, Suite B,
Gainesville, Florida
32653
United States,
(386) 418-8060
www.cyclotherapeutics.com
Cyclo Therapeutics is a clinical-stage biotechnology company focused on developing transformative therapies for rare and neurological diseases with limited treatment options. The Company’s investigational Trappsol Cyclo™, an orphan drug designated product in the United States and Europe, is the subject of four formal clinical trials for Niemann-Pick Disease Type C, a rare and fatal genetic disease, (www.ClinicalTrials.gov NCT02939547, NCT02912793, NCT03893071 and NCT04860960). It is conducting a Phase 2b clinical trial using Trappsol Cyclo intravenously in early Alzheimer’s disease (NCT05607615) based on encouraging data from an Expanded Access program for Alzheimer’s disease (NCT03624842). Cyclo Therapeutics is based in Gainesville, Florida
| Year | ≤ '20 | '21 | '22 | '23 | '24 | '25 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.2/yr) | # | - | - | - | 1 | - | - | 1 |
| Sell (0.0/yr) | # | - | - | - | - | - | - | 0 |
| 1 | ||||||||
| Legal | Deals |
|---|---|
|
Fox Rothschild |
1 |
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.